Ipilimumab/NivolumabDiabetes and hypophysitis

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1984卷 / 1期

关键词：

D O I：

10.1007/s40278-023-50512-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：281 / 281

相关论文

共 50 条

[1] Ipilimumab/nivolumabDiabetes mellitus: case report
Reactions Weekly, 2019, 1775 (1) : 269 - 269
[2] Ipilimumab/NivolumabHypercortisolism and hypophysitis
Reactions Weekly, 2024, 2013 (1) : 229 - 229
[3] Ipilimumab/nivolumabAutoimmune hypophysitis
Reactions Weekly, 2023, 1985 (1) : 271 - 271
[4] Ipilimumab/NivolumabHyperthyroidism and hypophysitis
Reactions Weekly, 2024, 2006 (1) : 342 - 342
[5] Ipilimumab/nivolumabDiabetes and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1958 (1) : 288 - 288
[6] Ipilimumab-Induced Hypophysitis
Usama, Muhammad
Mir, Tanveer
Fida, Ania
Mohsin, Syed Umer
Ali, Hammad
Raziq, Fazal I.
Khan, Muhammad Shayan
Levine, Diane
AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (06) : E761 - E763
[7] Ipilimumab, a cause of autoimmune hypophysitis
de Hollanda, Ana
Aranda, Gloria B.
Mora, Mireia
Gaba, Lydia
Halperin, Irene
ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (10): : 604 - 606
[8] Ipilimumab/methylprednisolone/nivolumabDiabetes and progression of granulomatosis with polyangiitis: case report
Reactions Weekly, 2021, 1872 (1) : 266 - 266
[9] Ipilimumab/nivolumabAutoimmune hypophysitis: case report
Reactions Weekly, 2019, 1734 (1) : 291 - 291
[10] IPILIMUMAB-INDUCED SECONDARY HYPOPHYSITIS
Cheema, Arvinder
ENDOCRINE PRACTICE, 2018, 24 (09) : 854 - 854

← 1 2 3 4 5 →